发明名称 |
TARGETED CANCER THERAPY USING ETS TRANSCRIPTIONAL INHIBITORS |
摘要 |
The present invention generally concerns methods and compositions for treating an individual with cancer utilizing polypeptide mutants of TEL. In particular embodiments, TEL polypeptides or peptides are employed having mutations at one or more of phosphorylation, acetylation, glycosylation, ubiquitination, or sumoylation sites, for example. |
申请公布号 |
WO2012112869(A3) |
申请公布日期 |
2012.10.11 |
申请号 |
WO2012US25608 |
申请日期 |
2012.02.17 |
申请人 |
SCOTT & WHITE HEALTHCARE;CAO, XIAOBO;SMYTHE, WILLIAM, ROY;GIZACHEW, DAWIT |
发明人 |
CAO, XIAOBO;SMYTHE, WILLIAM, ROY;GIZACHEW, DAWIT |
分类号 |
C07K14/435;A61K38/17;A61P35/00 |
主分类号 |
C07K14/435 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|